Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors

Area of Science:

• Oncology
• Biomarkers
• Liquid Biopsy

Background:

• Circulating tumor cells (CTCs) are crucial biomarkers in solid tumors, offering non-invasive insights into cancer progression and treatment response.
• Their detection in peripheral blood holds significant predictive and prognostic value across various solid tumor malignancies.
• Understanding CTCs is vital for advancing personalized medicine and precision oncology.

Purpose of the Study:

• To synthesize current knowledge on the role of CTCs in predicting clinical outcomes and prognosis in solid tumors.
• To analyze CTC detection methodologies, clinical relevance, challenges, and recent technological advancements.
• To examine the integration of CTC-based liquid biopsies into clinical practice for guiding treatment decisions and monitoring efficacy.

Main Methods:

• Narrative literature review.
• Descriptive and critical analysis of existing research on CTCs.
• Focus on recent advancements and emerging technologies in CTC detection.

Main Results:

• CTCs serve as early indicators of disease recurrence, metastatic potential, and therapeutic resistance.
• The dynamic nature of CTCs has significant implications for personalized medicine strategies.
• Advancements in detection technologies are enhancing the clinical utility of CTCs.

Conclusions:

• CTCs are transformative predictive and prognostic biomarkers in solid tumor management.
• Liquid biopsies utilizing CTCs are increasingly integrated into clinical practice for precision oncology.
• Further understanding and application of CTCs will significantly advance cancer care and patient outcomes.